Leading Executives in Medical Laboratories
Adam H. Schechter
Chairman, President & CEO, Labcorp
Chairman, President & CEO since 2019/2020, Adam Schechter has focused Labcorp on growth in diagnostics and strategic deals to expand specialty testing and partnerships.
Company bio/IR | LinkedIn (company)
Jim Davis
Chairman, CEO & President, Quest Diagnostics
Jim Davis serves as Chairman, CEO & President and led Quest’s international expansion, including the completed acquisition of LifeLabs on August 26, 2024.
Press release (role confirmation) | LinkedIn (company)
Jerry W. Hussong, MD, MBA
Chief Executive Officer, Sonic Healthcare USA
Jerry Hussong, MD, MBA is CEO of Sonic Healthcare USA, noted for scaling national responses in COVID-19 and monkeypox testing through federal collaborations.
Media (Sonic USA) | LinkedIn (company)
Colin Goldschmidt, MD
CEO & Managing Director, Sonic Healthcare (Global)
Dr. Colin Goldschmidt is the long‑tenured CEO & Managing Director of Sonic Healthcare Limited, a global diagnostics leader across Australasia, Europe, and the U.S.
Company site | LinkedIn (company)
Gilles G. J. Martin, PhD
Chairman and CEO (executive chair) or equivalent, Eurofins Scientific
Eurofins founder Gilles Martin built the company into a network of 900+ labs in 60+ countries and continues to lead as chairman and CEO/executive chair.
Company site | LinkedIn (company)
Andy Theurer, BS, CPA
Chief Executive Officer, ARUP Laboratories
Andy Theurer became CEO in 2021 and has overseen growth initiatives and national advocacy on LDT policy while keeping ARUP a top U.S. reference lab.
Company bio | LinkedIn (company)
William G. Morice II, MD, PhD
President & CEO, Mayo Clinic Laboratories
A hematopathologist and industry voice, Dr. Bill Morice is President & CEO of Mayo Clinic Laboratories and serves as board chair of the American Clinical Laboratory Association.
Faculty/leader profile | LinkedIn (company)
Craig Allen
President & Chief Executive Officer, BioReference Health (OPKO)
Craig Allen leads BioReference Health as President & CEO, guiding operations and portfolio focus through recent asset transactions.
Executive team page | OPKO leadership (parent) | LinkedIn (company)
Charles Brown
President & Chief Executive Officer, LifeLabs (a Quest Diagnostics company)
Charles Brown continues as President & CEO of LifeLabs following Quest Diagnostics’ acquisition closing on August 26, 2024, keeping the LifeLabs brand and team in Canada.
Company newsroom | LinkedIn (company)
Tony Zook
Chief Executive Officer, NeoGenomics Laboratories
Tony Zook, a former AstraZeneca executive and NeoGenomics board member, became CEO in April 2025 to drive execution and access to community oncology diagnostics.
Executive bio (IR) | LinkedIn (company)
Helmy Eltoukhy, PhD
Chairman & Co‑Chief Executive Officer, Guardant Health
Helmy Eltoukhy co‑founded Guardant Health and serves as chairman & co‑CEO, helping pioneer liquid biopsy tests for cancer screening and care.
Leadership page | LinkedIn (company)
AmirAli Talasaz, PhD
Co‑Chief Executive Officer, Guardant Health
Co‑founder AmirAli Talasaz serves as co‑CEO, advancing Guardant’s precision oncology diagnostics across screening, treatment selection and monitoring.
Leadership page | LinkedIn (company)
Steve Chapman
Chief Executive Officer, Natera
Steve Chapman has led Natera as CEO since 2019, growing its cell‑free DNA platform across oncology, women’s health and transplant testing.
Company news (IR) | LinkedIn (company)
Kevin Conroy
Chairman & Chief Executive Officer, Exact Sciences
Kevin Conroy, Chairman & CEO since 2009/2014, led Exact Sciences’ Cologuard launch and expansion into multi‑cancer early detection and MRD testing.
Leadership bio | LinkedIn (company)
Dan Malarek
Chief Executive Officer, Foundation Medicine (a Roche company)
Former Roche Diagnostics executive Dan Malarek was appointed CEO to accelerate Foundation Medicine’s next phase in comprehensive genomic profiling.
Press release (CEO) | LinkedIn (company)
Eric Lefkofsky
Founder & Chief Executive Officer, Tempus AI
Entrepreneur Eric Lefkofsky founded and leads Tempus AI, which went public in 2024 and builds AI‑driven precision‑medicine diagnostics across multiple diseases.
Company site | LinkedIn (company)
David D. Halbert
Founder, Chairman & Chief Executive Officer, Caris Life Sciences
David D. Halbert founded Caris and leads as Chairman & CEO, guiding its AI‑enabled precision oncology platform through major financings and a 2025 Nasdaq debut.
Leader bio | LinkedIn (company)
Ben W. Davis, MD
Founder, Chairman & Chief Executive Officer, PathGroup
Ben W. Davis, MD, founder and long‑time CEO, has scaled PathGroup into one of the largest U.S. independent labs through organic growth and acquisitions.
Press release (investment/role) | LinkedIn (company)
Sam Raha
President & Chief Executive Officer, Myriad Genetics
Sam Raha was named President & CEO effective April 30, 2025, after roles leading diagnostics businesses at Agilent, Illumina and Life Technologies.
Leadership page | LinkedIn (company)
Katherine Stueland
President & Chief Executive Officer, GeneDx
Katherine Stueland, President & CEO since 2021, has driven rapid scaling of whole‑exome/genome testing and broadened access in pediatrics and newborn care.
Leadership page | LinkedIn (company)
Related Topics
Was this page helpful? We'd love your feedback — please email us at feedback@dealstream.com.